As of 2025-05-12, the Relative Valuation of ImmunoGen Inc (IMGN) is (8.43) USD. This relative valuation is based on P/E multiples. With the latest stock price at 31.23 USD, the upside of ImmunoGen Inc based on Relative Valuation is -127.0%.
The range of the Relative Valuation is (6.87) - (10.01) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 26.1x - 38.1x | 34.9x |
| Forward P/E multiples | 22.4x - 38.2x | 29.2x |
| Fair Price | (6.87) - (10.01) | (8.43) |
| Upside | -122.0% - -132.1% | -127.0% |
| Date | P/E |